Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
about
Disorders of gastrointestinal hypomotilityCisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study.Gastroparesis: current concepts and management.Relationship between antral distension and postprandial symptoms in functional dyspepsiaEvaluation of thermal water in patients with functional dyspepsia and irritable bowel syndrome accompanying constipation.Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersAcid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapsePostprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients.Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patientsRelations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy.Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.Drug treatment of functional dyspepsia.H(2) receptor antagonists and prokinetics in dyspepsia: a critical review.Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consultersInfluence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptyingRelationship between gastrointestinal and extra-gastrointestinal symptoms and delayed gastric emptying in functional dyspeptic patients.Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying.Cisapride: what can we learn from the rise and fall of a prokinetic?5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders.From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.The use of SmartPill for gastric monitoring.Emerging drugs for functional dyspepsia.Cisapride: a gastrointestinal prokinetic drug.Gastroparesis Updates on Pathogenesis and Management.Antroduodenal manometry in children and adults with severe non-ulcer dyspepsia.Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride.Dyspeptic symptoms and gastric emptying of solids in patients with functional dyspepsia. Role of Helicobacter pylori infection.Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.Functional dyspepsia: New insights into the pathophysiology.Delayed gastric emptying rates and impaired antral motility in children fulfilling Rome III criteria for functional abdominal pain.
P2860
Q28070278-03B8FF0F-3ADA-4DA0-A9D9-56BCC0B8EE83Q30470952-071752A5-08B7-4A27-9872-4669A6A0660AQ33781620-403D0C99-8379-49D5-9D2E-E58878CA5801Q33865864-DB308256-7E28-40B0-B3C7-8E81F208C99DQ33868502-AEF8B3CD-18DD-414A-B237-7976AACB887FQ34166903-01413C9D-239A-44FC-B0B6-3AC839737348Q34377365-870F52E8-4FBB-4748-8D27-0E69D66C6A3EQ34377869-BEFD674B-4EB5-4ABC-B8F1-9638380455FCQ34378245-F8D0CDEA-B20E-4D71-8F30-77891E00CB71Q34391483-6411CDB7-8570-4FCB-B973-821C427D0AEDQ34408544-A897F3F9-840A-49BE-B22F-112E3C42D514Q34408576-5381833B-747B-45E5-B100-DDBF39E3E455Q34508541-EE7107FD-BFAB-4EAF-A61D-3C8AD0878D0CQ34529448-C8DCADB9-7B3D-47B1-8441-E86E00815664Q34601078-2A6DEA2C-AE42-47DB-A877-A0F8395243C3Q35596859-2CBED36C-978A-49A1-92E1-A98EA259F7DAQ35597269-9FAF5ABD-E470-4BAE-B6D6-513105D72B87Q35615914-94ED7FD5-EF50-4E27-8F41-C41923CD8172Q35938435-8FA67074-1863-409D-AE76-42BBC8CE2595Q37880285-2529FE32-76F3-409D-887D-E098406A39D3Q37953385-E8FD00AC-0CBA-4FB1-8F92-4CD4E5EC1017Q38203217-9470E6E3-4850-415A-8479-21F3176F72D0Q38216491-52700D67-6672-465D-B6D2-08F56CBB01F6Q38342083-A02730F5-C2AC-4ED1-A1E0-164BEF1E01F8Q38570021-697E17C4-2BC3-41FB-A591-A52C37FA7C41Q39324779-1C934612-DE47-465A-B2F1-7EE742348FE7Q39482102-1E235F94-C324-4315-AE8C-6BF1E659D26FQ42721572-52CEC943-D166-4C19-93C8-FFE8E551D5DDQ43433150-A1663DE7-FF32-43C6-A224-E1CF318DE9C1Q43861622-C9D86499-7F72-49CA-A367-6F8FF39FA2A6Q47816254-2F41BE3E-D901-4E82-8919-AC4D11AF9FE3Q49614336-A8D522A8-7A4E-4D6E-AA99-E4E01E377E7EQ51362089-C4997EBA-36D1-4B43-9D4F-72637FCD4F62
P2860
Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Effect of chronic administrati ...... with idiopathic gastroparesis.
@ast
Effect of chronic administrati ...... with idiopathic gastroparesis.
@en
Effect of chronic administrati ...... with idiopathic gastroparesis.
@nl
type
label
Effect of chronic administrati ...... with idiopathic gastroparesis.
@ast
Effect of chronic administrati ...... with idiopathic gastroparesis.
@en
Effect of chronic administrati ...... with idiopathic gastroparesis.
@nl
prefLabel
Effect of chronic administrati ...... with idiopathic gastroparesis.
@ast
Effect of chronic administrati ...... with idiopathic gastroparesis.
@en
Effect of chronic administrati ...... with idiopathic gastroparesis.
@nl
P2093
P2860
P356
P1433
P1476
Effect of chronic administrati ...... with idiopathic gastroparesis.
@en
P2093
Corinaldesi R
Salgemini R
Stanghellini V
P2860
P304
P356
10.1136/GUT.28.3.300
P407
P577
1987-03-01T00:00:00Z